238 related articles for article (PubMed ID: 9931626)
1. [Esophageal carcinoma: guidelines in surgical therapy].
Kremer B; Marxsen J; Grimm H; Stoffregen C; Schmid A; Henne-Bruns D
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():284-9. PubMed ID: 9931626
[TBL] [Abstract][Full Text] [Related]
2. [Esophageal carcinoma -- current status in diagnosis and therapy].
Baumhoer D; Ramadori G
Z Gastroenterol; 2005 Apr; 43(4):399-409. PubMed ID: 15830307
[TBL] [Abstract][Full Text] [Related]
3. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
[TBL] [Abstract][Full Text] [Related]
4. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction.
Lerut T; Coosemans W; De Leyn P; Deneffe G; Topal B; Van de Ven C; Van Raemdonck D
Hepatogastroenterology; 1999; 46(26):717-25. PubMed ID: 10370600
[TBL] [Abstract][Full Text] [Related]
5. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
7. [Cancer of the esophagus (II): the results of surgery, anatomicopathological study and patient survival].
Torramadé JR; Hernández-Lizoain JL; Zornoza G; Pardo F; González J; Balén E; Regueira FM; Cienfuegos JA
Rev Esp Enferm Dig; 1992 Dec; 82(6):388-93. PubMed ID: 1493056
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer.
Kang CH; Kim YT; Jeon SH; Sung SW; Kim JH
Eur J Cardiothorac Surg; 2007 Feb; 31(2):154-60. PubMed ID: 17145185
[TBL] [Abstract][Full Text] [Related]
9. [Guidelines in therapy of esophageal carcinoma].
Junginger T; Dutkowski P
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():146-51. PubMed ID: 9574115
[TBL] [Abstract][Full Text] [Related]
10. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Elsaleh H; Farrell JJ; Crane CH
J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
[No Abstract] [Full Text] [Related]
11. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
13. The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma.
Solomon N; Zhuge Y; Cheung M; Franceschi D; Koniaris LG
Ann Surg Oncol; 2010 Mar; 17(3):791-803. PubMed ID: 19953332
[TBL] [Abstract][Full Text] [Related]
14. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
15. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
16. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
[TBL] [Abstract][Full Text] [Related]
17. [Current diagnosis and therapy of esophageal carcinoma].
Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant therapy in oesophageal cancer surgery].
Imdahl A
Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the therapeutic effect of esophagectomy with extended 2-field lymph node dissection for esophageal carcinoma].
Wu CR; Xue HC; Zhu ZH; Zhang ZB; Geng CY; Ma ZK; Guo Y; Gao J
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):630-3. PubMed ID: 20021954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]